Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10585071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report on the transplantation of a cardiac allograft from a donor with prolonged exposure to anorexigens. This event allowed us to not only examine the early pathological alterations that characterize anorexigen-induced valvular damage, but to also study the posttransplantation outcome after the donor heart had been removed from the offending milieu. A donor history of anorexigen use should be sought, and if detected, careful evaluation for underlying valvular disease should be entertained. Early valvulopathy may appear clinically mild yet pathologically significant. Our single-case experience also suggests that anorexigen-induced valvulopathy may be a progressive disorder despite removal of the heart from the causative environment.
Medical subject headings
- Appetite Depressants
- Fenfluramine
- Heart Transplantation
- Mitral Valve Insufficiency
- Phentermine
- Postoperative Complications
- Tissue Donors